Active Pharmaceutical Ingredient (API)

Palbociclib

CDK4/6 Inhibitor

Inhibits cyclin-dependent kinases 4 and 6, blocking cell cycle progression from G1 to S phase. Used for HR+/HER2- breast cancer.
Technical Profile
Reference Code
ONC1004
CAS Number
571190-30-2
Molecular Weight
447.50 g/mol
Chemical Class
N/A
Molecular Formula
C24H29N7O2
Therapeutic Class
N/A

Verified Brands

Medicines containing Palbociclib as an active ingredient.

Brand Name Manufacturer Formulation MRP
No verified brands found for this salt.